Pesquisar
Emergent BioSolutions Inc
EBSAdicionar à lista de desejos
8.130USD
+0.190+2.39%
Fechamento 05/18, 16:00（ET）Cotações atrasadas em 15 min
421.13MValor de mercado
PerdaP/L TTM
Mais detalhes de Emergent BioSolutions Inc Empresa
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Informações de Emergent BioSolutions Inc
Código da empresaEBS
Nome da EmpresaEmergent BioSolutions Inc
Data de listagemNov 15, 2006
CEOPapa (Joseph C)
Número de funcionários900
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 15
Endereço300 Professional Dr
CidadeGAITHERSBURG
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal20879
Telefone12406313200
Sitehttps://emergentbiosolutions.com/
Código da empresaEBS
Data de listagemNov 15, 2006
CEOPapa (Joseph C)
Executivos da empresa Emergent BioSolutions Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
114.67K
+22.10%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
89.36K
+28.36%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
79.44K
+31.90%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
59.03K
+16.71%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
271.92K
+59.83%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
155.93K
+64.20%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
146.77K
+68.21%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
Por RegiãoUSD
Nome
Receita
Proporção
Non-U.S Government
403.20M
54.27%
U.S.Government
36.70M
4.94%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
Outro
72.72%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.60%
Dimensional Fund Advisors, L.P.
5.34%
State Street Investment Management (US)
5.23%
American Century Investment Management, Inc.
4.73%
Vanguard Capital Management, LLC
4.38%
Outro
72.72%
Tipos de investidores
Investidores
Proporção
Investment Advisor
37.35%
Investment Advisor/Hedge Fund
31.07%
Hedge Fund
8.77%
Research Firm
3.93%
Individual Investor
3.86%
Pension Fund
1.01%
Bank and Trust
0.36%
Family Office
0.06%
Insurance Company
0.02%
Outro
13.55%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
412
42.30M
81.98%
-3.37M
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
3.92M
7.6%
+17.75K
+0.45%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.25M
4.36%
+112.27K
+5.25%
Dec 31, 2025
State Street Investment Management (US)
2.70M
5.22%
+250.62K
+10.25%
Dec 31, 2025
American Century Investment Management, Inc.
2.44M
4.72%
+57.06K
+2.40%
Dec 31, 2025
Charles Schwab Investment Management, Inc.
1.62M
3.13%
+237.15K
+17.16%
Dec 31, 2025
Palisade Capital Management, LLC
1.27M
2.45%
-160.25K
-11.24%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.25M
2.42%
-28.68K
-2.24%
Dec 31, 2025
Oak Hill Advisors, L.P.
1.11M
2.16%
--
--
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
Ver Mais
AdvisorShares Insider Advantage ETF
Proporção0.97%
Royce Quant Small-Cap Quality Value ETF
Proporção0.41%
State Street SPDR S&P Biotech ETF
Proporção0.28%
Federated Hermes MDT Small Cap Core ETF
Proporção0.23%
Harbor Human Capital Factor US Small Cap ETF
Proporção0.19%
Direxion Daily S&P Biotech Bull 3X Shares
Proporção0.18%
Pacer US Small Cap Cash Cows ETF
Proporção0.16%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.15%
Avantis US Small Cap Value ETF
Proporção0.14%
iShares Micro-Cap ETF
Proporção0.13%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
